BCAT2 and type 2 diabetes mellitus: Interestingly, supraphysiological supplementation of metformin (2 mM), a commonly prescribed drug for T2DM, for 12 h increases BCAT2 mRNA expression levels (30%) but significantly reduces it after 24 h in C2C12 myotubes.